1.42
price up icon2.16%   0.03
 
loading
전일 마감가:
$1.39
열려 있는:
$1.39
하루 거래량:
37,935
Relative Volume:
0.56
시가총액:
$73.02M
수익:
$18.11M
순이익/손실:
$-18.95M
주가수익비율:
-3.2457
EPS:
-0.4375
순현금흐름:
-
1주 성능:
-7.19%
1개월 성능:
-13.41%
6개월 성능:
-52.82%
1년 성능:
-39.57%
1일 변동 폭
Value
$1.39
$1.45
1주일 범위
Value
$1.36
$1.60
52주 변동 폭
Value
$1.325
$3.5807

에이다진 Stock (ADAG) Company Profile

Name
명칭
Adagene Inc Adr
Name
전화
-
Name
주소
-
Name
직원
138
Name
트위터
Name
다음 수익 날짜
2024-03-28
Name
최신 SEC 제출 서류
Name
ADAG's Discussions on Twitter

ADAG을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ADAG
Adagene Inc Adr
1.42 73.02M 18.11M -18.95M 0 -0.4375
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

에이다진 Stock (ADAG) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-31 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-06-25 개시 China Renaissance Buy
2021-03-08 개시 Goldman Buy
2021-03-08 개시 Jefferies Buy
2021-03-08 개시 Morgan Stanley Overweight

에이다진 주식(ADAG)의 최신 뉴스

pulisher
Apr 23, 2025

Adagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual Meeting - The Manila Times

Apr 23, 2025
pulisher
Apr 23, 2025

Adagene Inc. Announces Poster Presentation on ADG126 at ASCO 2025 Conference - Nasdaq

Apr 23, 2025
pulisher
Apr 23, 2025

Adagene Announces Upcoming Poster Presentation on Masked - GlobeNewswire

Apr 23, 2025
pulisher
Apr 07, 2025

Adagene to Present at Stifel's 2025 Virtual Targeted Oncology Forum - The Manila Times

Apr 07, 2025
pulisher
Apr 07, 2025

Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum - GlobeNewswire

Apr 07, 2025
pulisher
Apr 07, 2025

Adagene Reveals New Oncology Strategy: CEO Set for Major Investor Presentation - Stock Titan

Apr 07, 2025
pulisher
Apr 07, 2025

FY2025 Earnings Estimate for Adagene Issued By HC Wainwright - Defense World

Apr 07, 2025
pulisher
Apr 05, 2025

Adagene (NASDAQ:ADAG) Earns “Buy” Rating from HC Wainwright - Defense World

Apr 05, 2025
pulisher
Mar 27, 2025

Adagene stock hits 52-week low at $1.62 amid market challenges By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Adagene stock hits 52-week low at $1.62 amid market challenges - Investing.com

Mar 27, 2025
pulisher
Mar 25, 2025

Adagene (ADAG) to Release Quarterly Earnings on Thursday - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Adagene Reports 33% Overall Response Rate in Phase 2 Expansion of Muzastotug for MSS CRC, Highlights Financial Position and Future Milestones - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

Adagene Reveals Breakthrough Cancer Trial Results in 2024 Financial Update - Stock Titan

Mar 24, 2025
pulisher
Mar 14, 2025

Adagene Inc. (NASDAQ:ADAG) Short Interest Down 55.9% in February - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Adagene Inc. to Present ADG126 SAFEbody® Data at 11th Annual Immuno-Oncology 360⁰ Summit in Boston - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Adagene's Revolutionary Cancer Treatment Targets CTLA-4: Key Presentation Coming to IO360 Summit - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Adagene to Present at the Leerink Partners Global Biopharma Conference 2024, Business Wires News - AsiaOne

Mar 12, 2025
pulisher
Mar 07, 2025

Adagene Announces Participation At Leerink’s Global Healthcare Conference 2025 - BERNAMA

Mar 07, 2025
pulisher
Mar 07, 2025

Adagene to Present at Leerink’s Global Healthcare Conference 2025 - GlobeNewswire

Mar 07, 2025
pulisher
Mar 06, 2025

Adagene to Present at Leerink's Global Healthcare Conference 2025 - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Can Adagene's CEO Reveal New Strategic Plans at Upcoming Leerink Conference? - StockTitan

Mar 06, 2025
pulisher
Feb 27, 2025

Adagene Inc. to Initiate Phase 2 Trial of ADG126 for Colorectal Cancer with Enrollment Starting in April 2025 - Nasdaq

Feb 27, 2025
pulisher
Feb 27, 2025

Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer - GlobeNewswire

Feb 27, 2025
pulisher
Feb 27, 2025

Could This New Colorectal Cancer Trial Change Pre-Surgery Treatment? Adagene Tests ADG126 - StockTitan

Feb 27, 2025
pulisher
Feb 23, 2025

Head to Head Analysis: Rafael (NYSE:RFL) versus Adagene (NASDAQ:ADAG) - Defense World

Feb 23, 2025
pulisher
Feb 16, 2025

Short Interest in Adagene Inc. (NASDAQ:ADAG) Declines By 50.2% - MarketBeat

Feb 16, 2025
pulisher
Feb 13, 2025

Adagene Inc. (NASDAQ:ADAG) Short Interest Update - Defense World

Feb 13, 2025
pulisher
Feb 13, 2025

Head to Head Survey: Adagene (NASDAQ:ADAG) and Corvus Pharmaceuticals (NASDAQ:CRVS) - Defense World

Feb 13, 2025
pulisher
Feb 04, 2025

Morgan Stanley Downgrades Adagene (NASDAQ:ADAG) to Equal Weight - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Adagene Inc. (NASDAQ:ADAG) Sees Large Increase in Short Interest - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Adagene (NASDAQ:ADAG) Cut to “Equal Weight” at Morgan Stanley - Defense World

Feb 03, 2025
pulisher
Feb 01, 2025

FY2024 Earnings Estimate for Adagene Issued By HC Wainwright - MarketBeat

Feb 01, 2025
pulisher
Jan 31, 2025

HC Wainwright Estimates Adagene FY2029 Earnings - MarketBeat

Jan 31, 2025
pulisher
Jan 31, 2025

Morgan Stanley Downgrades Adagene to Equal Weight From Overweight -January 31, 2025 at 07:57 am EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 31, 2025

Adagene Inc. (NASDAQ:ADAG) Sees Significant Growth in Short Interest - Defense World

Jan 31, 2025
pulisher
Jan 30, 2025

Adagene Reports Promising Results in Colorectal Cancer Study - TipRanks

Jan 30, 2025
pulisher
Jan 29, 2025

FY2029 Earnings Forecast for Adagene Issued By HC Wainwright - Defense World

Jan 29, 2025
pulisher
Jan 28, 2025

Adagene Announces Updated Data from Phase 1b/2 Study of - GlobeNewswire

Jan 28, 2025
pulisher
Jan 27, 2025

Adagene (NASDAQ:ADAG) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

H.C. Wainwright lifts Adagene stock target to $8 on ASCO data - Investing.com

Jan 27, 2025
pulisher
Jan 27, 2025

Adagene reports positive colorectal cancer trial results - Investing.com India

Jan 27, 2025
pulisher
Jan 27, 2025

ADAGAdagene Inc. American Depositary Shares Latest Stock News & Market Updates - StockTitan

Jan 27, 2025

에이다진 (ADAG) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
자본화:     |  볼륨(24시간):